Starling Oncology STLNW
NASDAQ STLNW
$0.04 -0.01 (-21.32%)
As of: Sep 9, 2026 · 12:49 PM EDT

Starling Oncology (STLNW) Gross Margin Growth (1y) (2022 - 2026)

Analysis

Starling Oncology (STLNW) Gross Margin Growth (1y) (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Davita 11.90 Bn 11.22 Bn 1.16 Bn -38.00
2 RadNet 5.52 Bn 4.79 Bn 88.08 Mn 27.00
3 Fresenius Medical Care AG 4.79 Bn 4.09 Bn 1.52 Bn 161.00
4 Concentra Group Holdings Parent 4.26 Bn 4.10 Bn 192.10 Mn 238.00
5 Privia Health 2.57 Bn 2.15 Bn - -
6 Pediatrix Medical 2.15 Bn 1.74 Bn - -
7 Progyny 2.11 Bn 1.87 Bn 89.30 Mn 175.00
8 Surgery Partners 1.84 Bn 1.63 Bn 622.10 Mn -69.00
9 U S Physical Therapy 1.17 Bn 1.15 Bn 41.94 Mn -150.00
10 Starling Oncology 4.13 Mn -36.96 Mn 27.17 Mn 223.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 223.00
Mar 31, 2026 -71.00
Dec 31, 2025 -576.00
Sep 30, 2025 -53.00
Jun 30, 2025 -3,820.00
Mar 31, 2025 -3,119.00
Dec 31, 2024 12,310.00
Sep 30, 2024 -3,081.00
Jun 30, 2024 875.00
Mar 31, 2024 391.00
Dec 31, 2023 -264.00
Sep 30, 2023 79.00
Jun 30, 2023 -198.00
Mar 31, 2023 -656.00
Dec 31, 2022 -145.00
Sep 30, 2022 -703.00
Jun 30, 2022 -667.00
Mar 31, 2022 -211.00